Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3026144 | 0.90 | CAPN1 (0.48) | CAPN1DPP4TACR1MAPTMEN1 | |
| SCHEMBL3015902 | 0.83 | CAPN1 (0.45) | CAPN1GLAMAPTMEN1KMT2A | |
| SCHEMBL3010581 | 0.81 | DPP4 (0.37) | DPP4TACR1KMT2AMAPK14GRIN1 | |
| SCHEMBL3021484 | 0.81 | CAPN1 (0.43) | CAPN1TACR1MDM2GRIN1GRIN2B | |
| SCHEMBL3799444 | 0.80 | TACR1 (0.35) | DPP4TACR1MAPK14GRIN1GRIN2B | |
| SCHEMBL27797712 | 0.78 | CAPN1 (0.40) | CAPN1GLAMAPTMEN1KMT2A | |
| SCHEMBL3031709 | 0.78 | CAPN1 (0.45) | CAPN1GLAMAPTMEN1KMT2A | |
| SCHEMBL27750542 | 0.78 | MAPT (0.46) | CAPN1DPP4MAPTMEN1KMT2A | |
| SCHEMBL3022057 | 0.77 | CAPN1 (0.43) | CAPN1DPP4TACR1MAPTMEN1 | |
| SCHEMBL13799188 | 0.76 | CAPN1 (0.48) | CAPN1DPP4TACR1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| CN-101677540-A | Herbicidally effective composition | EIKE HUPE | 2010-03-24 | — | — | CN | claimed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| CN-101677540-A | Herbicidally effective composition | EIKE HUPE | 2010-03-24 | — | — | CN | disclosed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | disclosed |
| CN-101365687-A | Piperazine compounds having herbicidal action | BASF SE (DE) | 2009-02-11 | — | — | CN | disclosed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | CAPN1 3690/4885DPP4 1470/4885TACR1 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.